LONDON--(Marketwire - July 23, 2008) - Curidium Medica plc, (LSE: CUR), the
personalised medicine company focused on bringing the right drug to the
right patient, today announced that Gosse B. Bruinsma M.D. is moving
from chairman to the position of Non-Executive Director. Dr. Barry
Porter, co-founder and currently Non-Executive Director,
becomes Chairman, with immediate effect. Dr. Bruinsma has cited his
other business obligations and Curidium's need for dedicated leadership
at this important time as reasons for the strategic change.
